Source: International Congress 2017 – COPD management: new findings from large studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Labaki (Ann Arbor, United States of America). Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort. 1494

Member's Comments

No comment yet.

Related content which might interest you: Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 The 2006 and 2011 GOLD classifications and five-years mortality in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Validation of the GOLD 2017 classification in a Chinese COPD cohort Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 GOLD classifications and mortality in COPD: The HUNT study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort Source: Eur Respir J 2013; 42: 636-646 Year: 2013 COPD severity using GOLD 2017 in real life: The French Palomb Cohort Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts Source: Eur Respir J 2013; 42: 1391-1401 Year: 2013 Characteristics of GOLD 2011 grading system in the COPDGene cohort Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality? Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD) Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data Source: ERJ Open Res, 6 (4) 00253-2020; 10.1183/23120541.00253-2020 Year: 2020 Late Breaking Abstract - Optimizing FEV1/FVC threshold to predict COPD hospitalization and mortality: NHLBI pooled cohorts study Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018